Market Research Report
E-pharmacy Market By Drug class (OTC Drugs, and Prescription Drugs), and by Region - Global Industry Insights, and Forecast to 2025
|Published by||Coherent Market Insights||Product code||664142|
|Published||Content info||182 Pages
Delivery time: 2-3 business days
|E-pharmacy Market By Drug class (OTC Drugs, and Prescription Drugs), and by Region - Global Industry Insights, and Forecast to 2025|
|Published: April 25, 2018||Content info: 182 Pages||
E-pharmacy is also known as internet pharmacy, online pharmacy or mail-order pharmacy. E-pharmacy companies operates online and deliver their products to its customers through shipping chains. E-pharmacy platform provides all types of pharmaceutical drugs such as OTC drugs, prescription products, and personal care products to its customers. Customers only have to upload their prescriptions online for getting prescription drugs. However, sales of illegal drugs is a major problem in online pharmacies. However, governments and regulatory bodies are working on reducing it by making various rules and regulations. For instance, the U.S. food and Drug Administration (FDA) has prohibited the import of drugs in the U.S., and E-pharmacy companies who want to sell its products in the U.S. need to have their physical presence in the country. Furthermore, the company has to take state wise license to sell and deliver its products in respective state.
Increasing investment and funding in key region such as Asia Pacific and Europe to scale up and expand their online pharmacy business and this is expected to drive growth of the global E-pharmacy market in the near future. For instance, in 2017, Zur Rose AG, a Switzerland-based online pharmacy company raised US$ 237 million to expand its business in Germany. Furthermore, the increasing usage of internet is also expected to drive the growth of market. For instance, according to data published by the World Bank around 87.5% of total population of U.K. were using internet in 2012, which has increased to 94.8% in 2016. Strategies deployed by major E-pharmacy key players such as free delivery, and lucrative offers and discounts is also expected to increase the adoption of E-pharmacy by population. For instance, in April 2018, Netmeds, an India-based E-pharmacy startup, is providing 20% discounts offers on its medicines. Moreover, these kinds of discount are widely aiding in growth of the market. Increasing prevalence of lifestyle diseases such as high blood pressure, diabetes, cardiovascular diseases, and obesity etc. is also expected to increase demand from products from E-pharmacy. For instance, according to data published by World Health Organization (WHO), globally, the number of people with diabetes increased from 108 million in 1980 to 422 million in 2014. According to WHO in 2017, cardiovascular diseases is the leading cause of death worldwide, about 17.7 million died from cardiovascular diseases in 2015.
"*" marked represents similar segmentation in other categories in the respective section.